Ryvu Therapeutics S.A. (RVU.WA)
PLN 36.5
(-3.95%)
PLN 36.5
(-3.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -79.53 Million | 21.31 Million | -57.86 Million | -10.63 Million | -17.4 Million | -36.41 Million |
| Net Income | -92.11 Million | -83.78 Million | -77.53 Million | -31.68 Million | -35.99 Million | 892.48 Thousand |
| Depreciation & Amortization | 10.97 Million | 12.9 Million | 12.56 Million | 12.35 Million | 9.1 Million | 8.22 Million |
| Deferred income taxes | -8.31 Million | -22.18 Million | -22.99 Million | 898.32 Thousand | -160.89 Thousand | - |
| Stock-based compensation | 8.31 Million | 22.18 Million | 22.99 Million | - | - | - |
| Change in working capital | -14.27 Million | 66.23 Million | -15.34 Million | 14.49 Million | 18.63 Million | -31.77 Million |
| Other non-cash items | 15.88 Million | 25.97 Million | 22.45 Million | -5.79 Million | -9.14 Million | -13.75 Million |
| Investing Cash Flow | -200.65 Million | 690 Thousand | 8.05 Million | -55.94 Million | -7.93 Million | -37.19 Million |
| Investments in PPE | -8.57 Million | -9.28 Million | -11.98 Million | -34.17 Million | -23.99 Million | -23.44 Million |
| Acquisitions | - | - | - | - | 80 Thousand | -40.18 Thousand |
| Investment purchases | -192.61 Million | -528 Thousand | -4.99 Million | -24.96 Million | -80 Thousand | -14.92 Million |
| Sales/Maturities of investments | - | 4.99 Million | 24.96 Million | 2.98 Million | 14.92 Million | 10.62 Million |
| Other Investing Activities | 535 Thousand | 5.51 Million | 61.43 Thousand | 218.85 Thousand | 1.12 Million | -9.4 Million |
| Financing Cash Flow | 240.93 Million | -2.45 Million | -3.16 Million | 130.68 Million | 2.58 Million | 147.86 Million |
| Debt repayment | -620 Thousand | -702 Thousand | -791.17 Thousand | -819.1 Thousand | -881.25 Thousand | -920.65 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -2.98 Million | - |
| Common Stock Issuance | 242.59 Million | - | 237.06 Thousand | 143.05 Million | - | 134.2 Million |
| Other Financing Activities | -1.04 Million | -1.75 Million | -2.61 Million | -11.54 Million | 6.45 Million | 14.58 Million |
| Accounts receivables | -15.9 Million | -5.56 Million | -3.79 Million | 3.74 Million | 11.67 Million | -24.06 Million |
| Accounts payables | 9.9 Million | -503 Thousand | 9.79 Million | -11.06 Million | -1.08 Million | 8.9 Million |
| Inventory | -360 Thousand | 198 Thousand | -281.11 Thousand | -89.55 Thousand | -682.73 Thousand | -398.36 Thousand |
| Other working capital | -7.91 Million | 72.09 Million | -21.06 Million | 21.89 Million | 8.73 Million | -31.38 Million |
| Cash at beginning of period | 344.87 Million | 83.23 Million | 136.21 Million | 72.1 Million | 94.85 Million | 36.12 Million |
| Cash at end of period | 57.93 Million | 101.91 Million | 83.23 Million | 136.21 Million | 72.1 Million | 110.37 Million |
| Capital Expenditure | -8.57 Million | -9.28 Million | -11.98 Million | -34.17 Million | -23.99 Million | -23.44 Million |
| Effect of forex changes on cash | -4.72 Million | -872 Thousand | - | - | 0.31 | - |
| Net cash flow / Change in cash | -286.94 Million | 18.68 Million | -52.98 Million | 64.11 Million | -22.75 Million | 74.24 Million |
| Free Cash Flow | -88.11 Million | 12.03 Million | -69.84 Million | -44.81 Million | -41.39 Million | -59.86 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.41 Million | -19.39 Million | -27.75 Million | -92.11 Million | -18.25 Million | -28.5 Million |
| Depreciation & Amortization | 2.7 Million | 2.76 Million | 2.62 Million | 10.97 Million | 2.77 Million | 2.78 Million |
| Deferred income taxes | - | - | -8.31 Million | -8.31 Million | - | - |
| Stock-based compensation | - | - | 8.31 Million | 8.31 Million | - | - |
| Change in working capital | 2.26 Million | -17.03 Million | 603 Thousand | -14.27 Million | 7.55 Million | -3.34 Million |
| Other non-cash items | -1.19 Million | 15.2 Million | 6.14 Million | 15.88 Million | 752 Thousand | 4.44 Million |
| Investing Cash Flow | -25.45 Million | 71.31 Million | 1 Million | -200.65 Million | -5.46 Million | -180.84 Million |
| Investments in PPE | -2.11 Million | -792 Thousand | -4.51 Million | -8.57 Million | -2.17 Million | 11.55 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 5.52 Million | -192.61 Million | -4.26 Million | -193.86 Million |
| Sales/Maturities of investments | -24.63 Million | 72.1 Million | - | - | - | - |
| Other Investing Activities | 2000.00 | -1000.00 | -1.00 | 535 Thousand | 977 Thousand | 1.46 Million |
| Financing Cash Flow | 34.55 Million | 33.98 Million | -358 Thousand | 240.93 Million | -360 Thousand | 12 Thousand |
| Debt repayment | -25.65 Million | -25.66 Million | -108 Thousand | -620 Thousand | -157 Thousand | -163 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -8.55 Million | 8.55 Million | - | 242.59 Million | - | - |
| Other Financing Activities | 68.93 Million | 1000.00 | -250 Thousand | -1.04 Million | -203 Thousand | 175 Thousand |
| Accounts receivables | 6.79 Million | -2.47 Million | 12.4 Million | -15.9 Million | -14.99 Million | -4.68 Million |
| Accounts payables | -11 Thousand | -11.19 Million | -5.22 Million | 9.9 Million | 22.35 Million | 1.57 Million |
| Inventory | -576 Thousand | - | -83 Thousand | -360 Thousand | -1000.00 | -277 Thousand |
| Other working capital | -1.23 Million | -3.36 Million | -6.48 Million | -7.91 Million | 207 Thousand | 35 Thousand |
| Cash at beginning of period | 129.71 Million | 57.93 Million | 79.65 Million | 344.87 Million | 93.76 Million | 300.83 Million |
| Cash at end of period | 112.46 Million | 129.71 Million | 57.93 Million | 57.93 Million | 79.65 Million | 93.76 Million |
| Capital Expenditure | -2.11 Million | -792 Thousand | -4.51 Million | -8.57 Million | -2.17 Million | 11.55 Million |
| Effect of forex changes on cash | -4.29 Million | 4.14 Million | -3.98 Million | -4.72 Million | -1.11 Million | -1.61 Million |
| Net cash flow / Change in cash | -17.25 Million | 71.78 Million | -21.71 Million | -286.94 Million | -14.1 Million | -207.07 Million |
| Free Cash Flow | -24.16 Million | -38.45 Million | -22.89 Million | -88.11 Million | -9.34 Million | -13.07 Million |
FCX
603083
EXAS
COX
2436
000710